Primary antitumor immune response mediated by CD4+ T cells A Corthay, DK Skovseth, KU Lundin, E Røsjø, H Omholt, PO Hofgaard, ... Immunity 22 (3), 371-383, 2005 | 572 | 2005 |
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis E Røsjø, A Lossius, N Abdelmagid, JC Lindstrøm, MT Kampman, ... Multiple Sclerosis Journal 23 (3), 395-402, 2017 | 71 | 2017 |
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis E Røsjø, KM Myhr, KI Løken-Amsrud, SJ Bakke, AG Beiske, KS Bjerve, ... Journal of neuroimmunology 271 (1-2), 60-65, 2014 | 52* | 2014 |
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis E Røsjø, LH Steffensen, L Jørgensen, JC Lindstrøm, J Šaltytė Benth, ... Journal of neurology 262, 2713-2721, 2015 | 47 | 2015 |
Vitamin D supplementation and neurofilament light chain in multiple sclerosis T Holmøy, E Røsjø, H Zetterberg, K Blennow, JC Lindstrøm, ... Acta Neurologica Scandinavica 139 (2), 172-176, 2019 | 34 | 2019 |
Natural variation of vitamin D and neurofilament light chain in relapsing-remitting multiple sclerosis E Røsjø, JC Lindstrøm, T Holmøy, KM Myhr, KN Varhaug, Ø Torkildsen Frontiers in Neurology 11, 329, 2020 | 15 | 2020 |
Selective intrathecal enrichment of G1m1‐positive B cells in multiple sclerosis A Lossius, A Tomescu‐Baciu, T Holmøy, CA Vedeler, E Røsjø, ... Annals of clinical and translational neurology 4 (10), 756-761, 2017 | 12 | 2017 |
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis–a case report T Holmøy, AG Beiske, S Zarnovicky, AZ Myro, E Røsjø, E Kerty BMC neurology 16, 1-5, 2016 | 5 | 2016 |
Vitamin A, D and E and inflammation in multiple sclerosis ER Røsjø | 1 | 2017 |
Vitamin A, D og E og multippel sklerose ER Røsjø Tidsskrift for Den norske legeforening, 2017 | | 2017 |
Effect of vitamin D supplementation on axonal damage in relapsing-remitting multiple sclerosis E Røsjø, T Holmøy, H Zetterberg, K Blennow, JC Lindstrøm, ... Akershus University Hospital, 0 | | |
Introductory remarks: shared tumor antigens in MM and their limitations in immunotherapy B Bogen, PA Ruffini, A Corthay, AB Fredriksen, M Frøyland, K Lundin, ... | | |